Cargando…

EGR1 regulates cellular metabolism and survival in endocrine resistant breast cancer

About 70% of all breast cancers are estrogen receptor alpha positive (ER+; ESR1). Many are treated with antiestrogens. Unfortunately, de novo and acquired resistance to antiestrogens is common but the underlying mechanisms remain unclear. Since growth of cancer cells is dependent on adequate energy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shajahan-Haq, Ayesha N., Boca, Simina M., Jin, Lu, Bhuvaneshwar, Krithika, Gusev, Yuriy, Cheema, Amrita K., Demas, Diane D., Raghavan, Kristopher S., Michalek, Ryan, Madhavan, Subha, Clarke, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722529/ https://www.ncbi.nlm.nih.gov/pubmed/29228577 http://dx.doi.org/10.18632/oncotarget.18292

Ejemplares similares

viGEN: An Open Source Pipeline for the Detection and Quantification of Viral RNA in Human Tumors
por: Bhuvaneshwar, Krithika, et al.
Publicado: (2018)

In Silico Discovery of Mitosis Regulation Networks Associated with Early Distant Metastases in Estrogen Receptor Positive Breast Cancers
por: Gusev, Yuriy, et al.
Publicado: (2013)

Metabolomic and exome sequence analysis reveal novel molecular signatures associated with colorectal cancer relapse
por: Gauba, Robinder, et al.
Publicado: (2012)

The REMBRANDT study, a large collection of genomic data from brain cancer patients
por: Gusev, Yuriy, et al.
Publicado: (2018)

CINdex: A Bioconductor Package for Analysis of Chromosome Instability in DNA Copy Number Data
por: Song, Lei, et al.
Publicado: (2017)

Targeting WEE1 Inhibits Growth of Breast Cancer Cells That Are Resistant to Endocrine Therapy and CDK4/6 Inhibitors
por: Fallah, Yassi, et al.
Publicado: (2021)

Mathematical modelling of breast cancer cells in response to endocrine therapy and Cdk4/6 inhibition
por: He, Wei, et al.
Publicado: (2020)

Evidence-Based Network Approach to Recommending Targeted Cancer Therapies
por: Kancherla, Jayaram, et al.
Publicado: (2020)

High mRNA expression of LY6 gene family is associated with overall survival outcome in pancreatic ductal adenocarcinoma
por: Russ, Eric, et al.
Publicado: (2021)

Genome sequencing analysis of blood cells identifies germline haplotypes strongly associated with drug resistance in osteosarcoma patients
por: Bhuvaneshwar, Krithika, et al.
Publicado: (2019)

A case study for cloud based high throughput analysis of NGS data using the globus genomics system
por: Bhuvaneshwar, Krithika, et al.
Publicado: (2014)

Enhancing the REMBRANDT MRI collection with expert segmentation labels and quantitative radiomic features
por: Sayah, Anousheh, et al.
Publicado: (2022)

Author Correction: Enhancing the REMBRANDT MRI collection with expert segmentation labels and quantitative radiomic features
por: Sayah, Anousheh, et al.
Publicado: (2022)

G-DOC Plus – an integrative bioinformatics platform for precision medicine
por: Bhuvaneshwar, Krithika, et al.
Publicado: (2016)

MYC regulates the unfolded protein response and glucose and glutamine uptake in endocrine resistant breast cancer
por: Shajahan-Haq, Ayesha N, et al.
Publicado: (2014)

Modeling breast cancer proliferation, drug synergies, and alternating therapies
por: He, Wei, et al.
Publicado: (2023)

Genome-wide multi-omics profiling of colorectal cancer identifies immune determinants strongly associated with relapse
por: Madhavan, Subha, et al.
Publicado: (2013)

Molecular predictors of response to pembrolizumab in thymic carcinoma
por: He, Yongfeng, et al.
Publicado: (2021)

Application of Metabolomics in Drug Resistant Breast Cancer Research
por: Shajahan-Haq, Ayesha N., et al.
Publicado: (2015)

Glutamine metabolism and the unfolded protein response in MYC-driven breast cancer
por: Shajahan-Haq, Ayesha, et al.
Publicado: (2014)

Glutamine Metabolism Drives Growth in Advanced Hormone Receptor Positive Breast Cancer
por: Demas, Diane M., et al.
Publicado: (2019)

G-CODE: enabling systems medicine through innovative informatics
por: Madhavan, Subha, et al.
Publicado: (2011)

ERRγ target genes are poor prognostic factors in Tamoxifen-treated breast cancer
por: Madhavan, Subha, et al.
Publicado: (2015)

Distinct lymphocyte antigens 6 (Ly6) family members Ly6D, Ly6E, Ly6K and Ly6H drive tumorigenesis and clinical outcome
por: Luo, Linlin, et al.
Publicado: (2016)

Discovery of Metabolic Biomarkers for Duchenne Muscular Dystrophy within a Natural History Study
por: Boca, Simina M., et al.
Publicado: (2016)

Modulation of Radiation Response by the Tetrahydrobiopterin Pathway
por: Pathak, Rupak, et al.
Publicado: (2015)

Pharmacogenomic characterization of gemcitabine response – a framework for data integration to enable personalized medicine
por: Harris, Michael, et al.
Publicado: (2014)

Differentially expressed miRNAs in triple negative breast cancer between African-American and non-Hispanic white women
por: Sugita, Bruna, et al.
Publicado: (2016)

Quantification and expert evaluation of evidence for chemopredictive biomarkers to personalize cancer treatment
por: Rao, Shruti, et al.
Publicado: (2016)

Correction: Discovery of Metabolic Biomarkers for Duchenne Muscular Dystrophy within a Natural History Study
por: Boca, Simina M., et al.
Publicado: (2016)

Integrated copy number and miRNA expression analysis in triple negative breast cancer of Latin American patients
por: Sugita, Bruna M., et al.
Publicado: (2019)

Resveratrol Inhibits KSHV Reactivation by Lowering the Levels of Cellular EGR-1
por: Dyson, Ossie F., et al.
Publicado: (2012)

Resistance to CDK4/6 Inhibitors in Estrogen Receptor-Positive Breast Cancer
por: Scheidemann, Erin R., et al.
Publicado: (2021)

Egr2 and Egr3 are the unique regulators for systemic autoimmunity
por: Sumitomo, Shuji, et al.
Publicado: (2013)

SPTBN1 inhibits inflammatory responses and hepatocarcinogenesis via the stabilization of SOCS1 and downregulation of p65 in hepatocellular carcinoma
por: Lin, Ling, et al.
Publicado: (2021)

Expression and prognostic value of the transcription factors EGR1 and EGR3 in gliomas
por: Knudsen, Arnon Møldrup, et al.
Publicado: (2020)

EGR1 controls divergent cellular responses of distinctive nucleus pulposus cell types
por: van den Akker, Guus G. H., et al.
Publicado: (2016)

The transcription factors Egr1 and Egr2 have opposing influences on adipocyte differentiation
por: Boyle, Keith B., et al.
Publicado: (2009)

MYC-Driven Pathways in Breast Cancer Subtypes
por: Fallah, Yassi, et al.
Publicado: (2017)

Real-world Studies Link NSAID Use to Improved Overall Lung Cancer Survival
por: Roszik, Jason, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_plt6p5sgr8dnspq1hosqnchhim